Literature DB >> 9284175

Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery.

P L Fidel1, W Luo, J Chabain, N A Wolf, E Van Buren.   

Abstract

Results from an animal model of vaginal candidiasis suggest that Candida-specific cell-mediated immunity in the systemic circulation does not mediate protection against vaginitis. The present study used cellular depletion analysis to examine the circulation of immune effector function between the vagina and the periphery. Results showed that anti-Thy-1.2 antibodies given intravenously to mice depleted Thy-1+ T lymphocytes in the systemic compartment but not in the vaginal mucosa, while the same antibodies injected intravaginally significantly reduced Thy-1+ T cells in both the vaginal and systemic compartments. These results support a lack or low level of circulation of immune effector function from the periphery to the vaginal mucosa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284175      PMCID: PMC175562          DOI: 10.1128/iai.65.9.3939-3943.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Langerhans cells and T lymphocyte subsets in the murine vagina and cervix.

Authors:  M B Parr; E L Parr
Journal:  Biol Reprod       Date:  1991-03       Impact factor: 4.285

2.  Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM).

Authors:  M A Thapar; E L Parr; J J Bozzola; M B Parr
Journal:  Vaccine       Date:  1991-02       Impact factor: 3.641

3.  Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.

Authors:  L Romani; S Mocci; C Bietta; L Lanfaloni; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

5.  Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.

Authors:  P Y Paterson; R Semo; G Blumenschein; J Swelstad
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

6.  Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis.

Authors:  I W Fong; P McCleary; S Read
Journal:  Am J Obstet Gynecol       Date:  1992-03       Impact factor: 8.661

7.  T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery.

Authors:  P L Fidel; N A Wolf; M A KuKuruga
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization.

Authors:  M A Thapar; E L Parr; M B Parr
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

9.  CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; P Mosci; P Puccetti; F Bistoni
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

10.  Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more
  5 in total

1.  T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis.

Authors:  C S Farah; S Elahi; G Pang; T Gotjamanos; G J Seymour; R L Clancy; R B Ashman
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.

Authors:  F de Bernardis; G Santoni; M Boccanera; E Spreghini; D Adriani; L Morelli; A Cassone
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis.

Authors:  Flavia De Bernardis; Maria Boccanera; Daniela Adriani; Antonietta Girolamo; Antonio Cassone
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.

Authors:  M B Parr; E L Parr
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.